Biology Reference
In-Depth Information
CHAPTER FIVE
Chemotherapeutic Strategies
for Reducing Transmission of
Plasmodium vivax
Malaria
Nicholas M. Douglas
*
,
†
,
‡
,
1
, George K. John
*
, Lorenz von Seidlein
†
,
Nicholas M. Anstey
†
,
‡
, Ric N. Price
*
,
†
,
‡
*Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford,
Oxford, UK
†
Global Health Division, Menzies School of Health Research and Charles Darwin University,
Darwin, Australia
‡
Department of Infectious Diseases, Division of Medicine, Royal Darwin Hospital, Darwin, Australia
1
Corresponding author: Email: nicholas.douglas@gmail.com
Contents
1. Introduction
272
2. Transmissionof
P. vivax
273
3. Reducing
P. vivax
TransmissionbyTreatingSymptomaticDisease
278
3.1. EradicatingBlood-StageParasites
279
3.2. Post-treatmentProphylaxis
281
3.3. EradicatingHypnozoites
282
4. Reducing
P. vivax
TransmissionUsingMassDrugAdministration
286
5. Conclusions
291
Abstract
Effective use of anti-malarial drugs is key to reducing the transmission potential of
Plasmodium vivax
. In patients presenting with symptomatic disease, treatment with
potent and relatively slowly eliminated blood schizontocidal regimens administered
concurrently with a supervised course of 7 mg/kg primaquine over 7-14 days has
potential to exert the greatest transmission-blocking benefit. Given the spread of
chloroquine-resistant
P. vivax
strains,theartemisinincombinationtherapiesdihydroar-
temisinin + piperaquineandartesunate + mefloquinearecurrentlythemostassured
means of preventing
P. vivax
recrudescence. Preliminary evidence suggests that, like
chloroquine,thesecombinationspotentiatethehypnozoitocidaleffectofprimaquine,
butfurthersupportiveevidenceisrequired.Inviewofthehighrateof
P. vivax
relapse
followingfalciparuminfectionsinco-endemicregions,thereisastrongargumentfor
broadeningcurrentradicalcurepolicytoincludetheadministrationofhypnozoitocidal
dosesofprimaquinetopatientswith
Plasmodium falciparum
malaria.Themostimpor-
tant reservoir for
P. vivax
transmission is likely to be very low-density, asymptomatic